4.7 Article

LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis

Journal

CANCER LETTERS
Volume 434, Issue -, Pages 172-183

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2018.07.016

Keywords

Glut1; Oral squamous cell carcinoma (OSCC); Long non-coding RNA; Glycolysis; Metastasis

Categories

Funding

  1. National Natural Science Foundation of China [81502356, 81500864, 81272948]
  2. Nonprofit Industry Research Specific Fund of National Health and Family Planning Commission of China [201502018]
  3. Science and Technology Program of Guangzhou, China [201804010040]
  4. Postdoctoral Science Foundation of China [2015M570748, 2016T90819]

Ask authors/readers for more resources

The dysregulation of glycolysis has been suggested to lead to alteration of cell drug resistance signals, proliferation and metastasis. Emerging evidence indicates that lncRNAs play a key role in the cellular processes of tumor cells, including glycolysis, growth, and movement. However, the role and potential mechanism of lncRNAs in glycolysis-mediated metastasis has not been explored. In this study, we identified a novel lncRNA lnc-p23154 which is associated with OSCC patient metastasis and the promotion of OSCC cell migration and invasion in vitro and in vivo. Furthermore, we found that lnc-p23154 also participates in OSCC glycolysis by facilitating Glut1 expression. Rescue of lnc-p23154 reversed the suppression of OSCC cell migration and invasion induced by Glut1 knockdown. In addition, Inc-p23154 is mainly located in the nucleus and binds to the promoter region of miR-378a-3p, which represses Glut1 expression by targeting to its 3'UTR directly. Therefore, we concluded that Inc-p23154 may play an important role in Glut1-mediated glycolysis by inhibiting miR-378a-3p transcription and accelerate OSCC metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Dentistry, Oral Surgery & Medicine

Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression in an Immune Microenvironment

L. Wen, W. Mu, H. Lu, X. Wang, J. Fang, Y. Jia, Q. Li, D. Wang, S. Wen, J. Guo, W. Dai, X. Ren, J. Cui, G. Zeng, J. Gao, Z. Wang, B. Cheng

JOURNAL OF DENTAL RESEARCH (2020)

Article Dentistry, Oral Surgery & Medicine

Dysfunctional role of elevated TIGIT expression on T cells in oral squamous cell carcinoma patients

Xiangqi Liu, Qunxing Li, Ying Zhou, Xinlin He, Juan Fang, Huanzi Lu, Xi Wang, Dikan Wang, Da Ma, Bin Cheng, Guiqing Liao, Zhi Wang

Summary: The study revealed that T-cell expression of TIGIT is elevated in patients with oral squamous cell carcinoma (OSCC) and is associated with T stage and nodal invasion. Additionally, TIGIT-expressing T cells display a dysfunctional and inhibitory phenotype, while TIGIT blockade enhances proliferation ability and cytokine production in CD4(+) and CD8(+) T cells.

ORAL DISEASES (2021)

Article Oncology

Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome

Xi Wang, Yiqun Jia, Liling Wen, Wenxin Mu, Xianrui Wu, Tao Liu, Xiangqi Liu, Juan Fang, Yizhao Luan, Ping Chen, Jinlong Gao, Ky-Anh Nguyen, Jun Cui, Gucheng Zeng, Ping Lan, Qianming Chen, Bin Cheng, Zhi Wang

Summary: The study reveals that the periodontal pathogen P. gingivalis can promote colorectal tumorigenesis by recruiting myeloid cells and creating a proinflammatory tumor microenvironment.

CANCER RESEARCH (2021)

Review Cell Biology

TCF-1 maintains CD8+ T cell stemness in tumor microenvironment

Shuqiong Wen, Huanzi Lu, Dikan Wang, Junyi Guo, Wenxiao Dai, Zhi Wang

Summary: TCF-1 plays a crucial role in T cell development and memory formation, while exhausted CD8(+) T cells expressing this factor may have a stimulating effect on enhancing immune response and improving response to immunotherapy. Intratumoral exhausted CD8(+) T cells expressing TCF-1 represent a subset with stem cell-like properties associated with improved antitumor immunity and response to immune checkpoint blockade.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Review Immunology

Crosstalk between the oral microbiota, mucosal immunity, and the epithelial barrier regulates oral mucosal disease pathogenesis

Dongjia Lin, Lisa Yang, Liling Wen, Huanzi Lu, Qianming Chen, Zhi Wang

Summary: Oral mucosal disease (OMD), also known as soft tissue oral disease, is a range of disorders affecting the mucosa and soft tissue in the oral cavity. The unclear etiology may involve dysbiosis of oral mucosa and saliva-resident microbiota, impacting immune response and epithelial barrier function, leading to OMD. Research suggests diverse oral microbial dysbiosis in different diseases, implying potential causal pathogens across various oral pathologies. This literature review explores how microbial dysbiosis interacts with mucosal adaptive immune cells and the epithelial barrier in OMD, focusing on representative OMDs including oral candidiasis, oral lichen planus, recurrent aphthous ulcer, oral leukoplakia, and oral squamous cell carcinoma.

MUCOSAL IMMUNOLOGY (2021)

Article Oncology

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy

Si-yuan Zhang, Xian-yue Ren, Chun-yang Wang, Xi-juan Chen, Ruo-yan Cao, Qin Liu, Xue Pan, Jia-ying Zhou, Wei-lin Zhang, Xin-Ran Tang, Bin Cheng, Tong Wu

Summary: The study classified OSCC patients into epithelial and mesenchymal phenotypes based on EMT signature genes, revealing that mesenchymal subtype tumors have higher immune cell infiltration and immunosuppressive characteristics. A novel prognostic classifier incorporating EMT score, immune checkpoint expressions, and TNM stages was developed and validated to improve prediction efficiency in OSCC.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Immune-related lncRNA classification of head and neck squamous cell carcinoma

Ruoyan Cao, Lin Cui, Jiayu Zhang, Xianyue Ren, Bin Cheng, Juan Xia

Summary: This study identifies subtypes of head and neck squamous cell carcinoma based on immune-related lncRNAs and characterizes their biological behaviors. The researchers found that certain subtypes are associated with good prognosis and sensitivity to immunotherapy, and identified a critical lncRNA TRG-AS1 involved in the tumor microenvironment. This provides new potential targets for the treatment of this subtype.

CANCER CELL INTERNATIONAL (2022)

Article Cell Biology

Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma

Zihang Ling, Wei Li, Jiaqi Hu, Yuanyuan Li, Miao Deng, Siyuan Zhang, Xianyue Ren, Tong Wu, Juan Xia, Bin Cheng, Xiaoan Tao

Summary: The CCL2-CCR4-Vav2-Rac1-p-MLC signaling pathway plays a critical role in the migration and metastasis of HNSCC, suggesting CCR4 as a potential molecular target for HNSCC therapy.

CELL DEATH & DISEASE (2022)

Article Cell Biology

Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells

Jianmin Peng, Qinchao Hu, Xijuan Chen, Chunyang Wang, Jiayu Zhang, Xianyue Ren, Yun Wang, Xiaoan Tao, Huan Li, Ming Song, Bin Cheng, Tong Wu, Juan Xia

Summary: Obesity promotes the incidence of oral squamous cell carcinoma by altering the immune microenvironment and increasing the number of myeloid-derived suppressor cells (MDSCs). Targeting MDSCs in cancer immunotherapy may have greater efficacy in obese patients with OSCC.

CELL DEATH & DISEASE (2021)

Article Dentistry, Oral Surgery & Medicine

SPDEF suppresses head and neck squamous cell carcinoma progression by transcriptionally activating NR4A1

Yanting Wang, Xianyue Ren, Weiyu Li, Ruoyan Cao, Suyang Liu, Laibo Jiang, Bin Cheng, Juan Xia

Summary: SPDEF acts as a tumor suppressor in HNSCC by transcriptionally activating NR4A1, leading to inhibition of AKT, MAPK, and NF-kappa B signaling pathways. Low expression of SPDEF is associated with poor clinical outcomes in HNSCC patients, and restoration of SPDEF inhibits cell proliferation in HNSCC.

INTERNATIONAL JOURNAL OF ORAL SCIENCE (2021)

Article Multidisciplinary Sciences

USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma

Yang Chen, Yin Zhao, Xiaojing Yang, Xianyue Ren, Shengyan Huang, Sha Gong, Xirong Tan, Junyan Li, Shiwei He, Yingqin Li, Xiaohong Hong, Qian Li, Cong Ding, Xueliang Fang, Jun Ma, Na Liu

Summary: This study demonstrates that the deubiquitinase USP44 enhances the radiosensitivity of nasopharyngeal carcinoma cells by promoting the degradation of Ku80. Low expression of USP44 is associated with poor prognosis and tumor relapse in clinical settings.

NATURE COMMUNICATIONS (2022)

Article Oncology

Comprehensive Analysis of the PRDXs Family in Head and Neck Squamous Cell Carcinoma

Ruoyan Cao, Weilin Zhang, Hongjian Zhang, Lixuan Wang, Xijuan Chen, Xianyue Ren, Bin Cheng, Juan Xia

Summary: The peroxidase family of peroxiredoxins (PRDXs) plays a vital role in maintaining the intracellular balance of ROS in head and neck squamous cell carcinoma (HNSCC). The expression of PRDX1, PRDX4, and PRDX5 in HNSCC is increased, while the expression of PRDX2 is decreased. Higher expression of PRDX4/5/6 indicates poor prognosis, while lower expression of PRDX1/5 is associated with more immune cell infiltration, higher expression of immune-related molecules, and a likely response to anti-PD-1 treatment. Knockdown of PRDX5 inhibits HNSCC cell proliferation, invasion, and metastasis, and promotes apoptosis through its antioxidant property. This study highlights the potential role of PRDXs, particularly PRDX5, in HNSCC and suggests it as a potential therapeutic target.

FRONTIERS IN ONCOLOGY (2022)

Article Endocrinology & Metabolism

Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma

Xijuan Chen, Qin Liu, Yingyao Chen, Lixuan Wang, Rongchun Yang, Weilin Zhang, Xue Pan, Siyuan Zhang, Chuwen Chen, Tong Wu, Juan Xia, Bin Cheng, Xiaobing Chen, Xianyue Ren

Summary: CES2 downregulation in OSCC plays a crucial role in maintaining lipid homeostasis and reducing lipotoxicity during tumor progression. Restoring CES2 expression can inhibit OSCC cell viability, migration, invasion, and tumor growth by reprogramming lipid metabolism and inducing mitochondrial dysfunction. Targeting CES2 may provide a potential therapeutic strategy for OSCC.

MOLECULAR METABOLISM (2022)

Article Cell Biology

TIPE3 represses head and neck squamous cell carcinoma progression via triggering PGAM5 mediated mitochondria dysfunction

Wei Chen, Xijuan Chen, Lixuan Wang, Rongchun Yang, Weilin Zhang, Siyuan Zhang, Juan Xia, Bin Cheng, Tong Wu, Xianyue Ren

Summary: Mitochondria are key in maintaining oxidative balance and cell death regulation during cancer cell growth. TIPE3 downregulation through promoter hypermethylation is the main alteration in TIPEs during HNSCC development.

CELL DEATH & DISEASE (2023)

Article Cell Biology

Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis

Yanting Wang, Yuanyuan Li, Laibo Jiang, Xianyue Ren, Bin Cheng, Juan Xia

Summary: The higher expression levels of glycolysis markers, including GLUT1, MCT4, HK2, and PKM2, are associated with poorer overall survival and disease-free survival in head and neck squamous cell carcinoma patients. These markers could serve as potential prognostic predictors and therapeutic targets in the management of HNSCC.

AGING-US (2021)

Review Oncology

Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy

Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu

Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.

CANCER LETTERS (2024)

Article Oncology

HMGB1 in the interplay between autophagy and apoptosis in cancer

Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang

Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.

CANCER LETTERS (2024)

Article Oncology

Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer

Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge

Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.

CANCER LETTERS (2024)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Oncology

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang

Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.

CANCER LETTERS (2024)